Skip to content
10-K

Annual Report

Nautilus Biotechnology, Inc. NAUT

0001808805-25-000008

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 21, 2025 126.15M sh
Shares Diluted FY 2024 · Dec 31, 2023 124.92M sh
Capex FY 2024 · Dec 31, 2023 $2.44M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$51.71M
Cash And Equivalents FY 2024 · Dec 31, 2023 $19.4M
Current Liabilities FY 2024 · Dec 31, 2023 $9.12M
Total Liabilities FY 2024 · Dec 31, 2023 $40.21M
Current Assets FY 2024 · Dec 31, 2023 $176.84M
Total Assets FY 2024 · Dec 31, 2023 $305.57M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.51
Eps Basic FY 2024 · Dec 31, 2023 −$0.51
Rd Expense FY 2024 · Dec 31, 2023 $47.25M
Net Income FY 2024 · Dec 31, 2023 −$63.68M
Stockholders Equity FY 2024 · Dec 31, 2022 $314.92M